Michal Czarnuch is an advocate admitted to practice in Poland, a partner in the corporate department of Rymarz Zdort Maruta and the head of the Life Sciences practice.
He is one of Poland’s most prominent lawyers practising in the broadly defined area of healthcare. He specialises in administrative law, in particular pharmaceutical law, laws governing medical devices, medicine, and advertising, as well as European and competition law, as well as compliance in cases involving allegations of corruption. He advises clients from the pharmaceutical and FMCG industries (including with respect to alcohol and tobacco products) on advertising and promotional activities, reimbursement, distribution, labelling and manufacturing, and quality control.
He provides advice on the establishment of distribution and marketing systems for medicinal products in matters related to healthcare systems, including the financing of healthcare services, the establishment and restructuring of healthcare providers, telemedicine and health insurance.
He has been involved in a number of legislative processes, including participation in the development of healthcare laws and the creation of opinions and reports on the functioning of these laws. He is one of the originators of the Telemedicine Working Group and a member of the management board of the Telemedicine Working Group Foundation. He advises on projects related to outsourcing and access to medical data in cooperation with the Ministry of Health and the Centre for Health Information Systems (CSIOZ), where he is a member of the Interoperability Council. He also serves as a member of the Advisory Team to the Senate Committee on Health.
He is a graduate of the Faculty of Law at the University of Warsaw. He was admitted to the bar in 2014. Since 2017, he has lectured in post-graduate studies programme titled “Management in the pharmaceutical sector” organised at Lazarski University.
Since 2012, he has been continuously recommended by Chambers Europe as one of the top Life Sciences legal practitioners in Poland. Michał Czarnuch advises domestic pharmaceutical companies on reimbursement and distribution issues. Clients rate his hands-on approach, one describing him as ‘pragmatic and solutions-oriented’.
The Legal 500 has named Michal Czarnuch as a leading individual in the Healthcare and Life Sciences area.
14 March 2024
We are going for a record! We are pleased to announce that in this year’s edition of the Chambers and Partners Europe ranking, nine of our practices have been ranked and as many as 21 lawyers have bee...
9 November 2023
The law firm of Rymarz Zdort Maruta, in line with its strategy, is continuing its dynamic growth by expanding the scope of support it provides to also cover the Life Sciences sector. Over the coming m...